Generic cholesterol drugs save Medicare billions of dollars: Between 2014 and 2018, the number of Medicare beneficiaries on cholesterol drugs went up, but total costs plummeted – Science Daily

Cholesterol Can Vanish Using Proven Natural Remedies

Generic Cholesterol Drugs Save Medicare Billions Of Dollars: Between 2014 And 2018, The Number Of Medicare Beneficiaries On Cholesterol Drugs Went Up, But Total Costs Plummeted - Science Daily

Science News from research organizations 1

Generic Cholesterol Drugs Save Medicare Billions Of Dollars: Between 2014 And 2018, The Number Of Medicare Beneficiaries On Cholesterol Drugs Went Up, But Total Costs Plummeted - Science Daily

2

Generic cholesterol drugs save Medicare billions of dollars

Generic Cholesterol Drugs Save Medicare Billions Of Dollars: Between 2014 And 2018, The Number Of Medicare Beneficiaries On Cholesterol Drugs Went Up, But Total Costs Plummeted - Science Daily

Between 2014 and 2018, the number of Medicare beneficiaries on cholesterol drugs went up, but total costs plummeted

Date:
September 9, 2020
Source:
UT Southwestern Medical Center
Summary:
The switch from brand name to generic cholesterol medications that occurred between 2014 and 2018 has saved Medicare billions of dollars, even as the number of people on cholesterol-lowering drugs has increased, scientists have calculated. Their data suggest that policymakers and clinicians could help cut Medicare costs even further by switching more patients to generic drugs.
Share:

FULL STORY

Generic Cholesterol Drugs Save Medicare Billions Of Dollars: Between 2014 And 2018, The Number Of Medicare Beneficiaries On Cholesterol Drugs Went Up, But Total Costs Plummeted - Science Daily

The switch from brand name to generic cholesterol medications that occurred between 2014 and 2018 has saved Medicare billions of dollars, even as the number of people on cholesterol-lowering drugs has increased, UT Southwestern scientists have calculated. Their data, published in the journal JAMA Cardiology, suggest that policymakers and clinicians could help cut Medicare costs even further by switching more patients to generic drugs.

Generic Cholesterol Drugs Save Medicare Billions Of Dollars: Between 2014 And 2018, The Number Of Medicare Beneficiaries On Cholesterol Drugs Went Up, But Total Costs Plummeted - Science Daily

advertisement

Generic Cholesterol Drugs Save Medicare Billions Of Dollars: Between 2014 And 2018, The Number Of Medicare Beneficiaries On Cholesterol Drugs Went Up, But Total Costs Plummeted - Science Daily

"One of the most important contributors to our health care costs is expenditure on prescription drugs," says Ambarish Pandey, M.D., a cardiologist and assistant professor of internal medicine at UTSW. "The switch to generics is an effective strategy to cut the costs incurred by health systems."

Generic Cholesterol Drugs Save Medicare Billions Of Dollars: Between 2014 And 2018, The Number Of Medicare Beneficiaries On Cholesterol Drugs Went Up, But Total Costs Plummeted - Science Daily

Pandey is considered a thought leader in how to leverage information gleaned from electronic health records and other health databases. He was named a Texas Health Resources Clinical Scholar in 2018 and has previously published papers on how much extended-release drugs cost the U.S. health care system, the burden of heart failure and heart attack-associated hospital readmission and mortality in the Medicare population, and the development of novel strategies to predict and prevent heart failure in this population, among other topics.

Generic Cholesterol Drugs Save Medicare Billions Of Dollars: Between 2014 And 2018, The Number Of Medicare Beneficiaries On Cholesterol Drugs Went Up, But Total Costs Plummeted - Science Daily

"It's important for our health care system to find avenues to become more cost-efficient and accessible. Even though there is still a lot of work to be done, it is encouraging to see how quickly patients switched to generic options once they became available," says first author Andrew Sumarsono, M.D., an assistant professor of internal medicine at UTSW. "This rapid switch to generics saved Medicare a lot of money."

In the U.S., 95 million adults have total cholesterol levels higher than 200 mg/dL, and most are recommended to lower their low-density lipoprotein (LDL) cholesterol through a combination of lifestyle changes and LDL-lowering medications. The most popular of these are statins, currently prescribed to more than 35 million people in the U.S.

Between 2010 and 2018, patents on a number of statins and other LDL-lowering drugs expired, enabling drugmakers to begin producing generic versions. The widely prescribed brand-name drugs Crestor and Zetia, for instance, both had patents expire during this time frame.

advertisement

In the new study, Pandey and his colleagues used the Medicare Part D Prescription Drug Event Database — which includes information on all outpatient drug spending for Medicare Part D beneficiaries. The data they analyzed spanned January 2014 through December 2018. Between 2014 and 2018, the number of Medicare Part D enrollees grew from 37.7 million to 44.2 million, and the total number of prescriptions for LDL-lowering drugs increased by 23 percent, from 20.5 million to 25.2 million.

Despite that increase in prescriptions for LDL-lowering drugs, total costs on these drugs went down. The number of prescriptions that were for generic drugs rose by 35 percent, from 17.8 million to 24 million. And the overall spending on statins declined by 52 percent, from $4.8 billion in 2014 to $2.3 billion in 2018.

"This really shows how prescription patterns can have a very big influence on health care costs," says Pandey.

During the timespan studied, Medicare still spent $9.6 billion on brand-name LDL-lowering medications and could have saved an additional $2.5 billion of that by switching to generics more quickly when they became available, the study found.

A newer class of LDL-lowering drugs, called PCSK9 inhibitors, became available in 2015; Pandey's group showed that prescriptions for these drugs were low and increased by 144 percent, from 25,569 to 62,476, between 2016 and 2018. Follow-up studies could investigate the effect PCSK9 has had on Medicare spending and prescriptions in the time since, Pandey says. He'd also like to study how out-of-pocket costs for patients have changed over time.

"Statins are one of the most important drugs to study in this context because they're just so widely prescribed," he adds. "But there are also other drugs that certainly have substantial costs to the health care system and need to be studied in this respect as well."

"It's amazing to see these drug advances in medicine," Sumarsono says. "But we also want to make sure that everyone who needs these drugs can afford them."

make a difference: sponsored opportunity

Story Source:

Materials provided by UT Southwestern Medical Center. Note: Content may be edited for style and length.

Journal Reference:

  1. Andrew Sumarsono, Hussain S. Lalani, Muthiah Vaduganathan, Ann Marie Navar, Gregg C. Fonarow, Sandeep R. Das, Ambarish Pandey. Trends in Utilization and Cost of Low-Density Lipoprotein Cholesterol–Lowering Therapies Among Medicare Beneficiaries. JAMA Cardiology, 2020; DOI: 10.1001/jamacardio.2020.3723

Cite This Page:

UT Southwestern Medical Center. "Generic cholesterol drugs save Medicare billions of dollars: Between 2014 and 2018, the number of Medicare beneficiaries on cholesterol drugs went up, but total costs plummeted." ScienceDaily. ScienceDaily, 9 September 2020. <www.sciencedaily.com/releases/2020/09/200909114837.htm>. UT Southwestern Medical Center. (2020, September 9). Generic cholesterol drugs save Medicare billions of dollars: Between 2014 and 2018, the number of Medicare beneficiaries on cholesterol drugs went up, but total costs plummeted. ScienceDaily. Retrieved September 10, 2020 from www.sciencedaily.com/releases/2020/09/200909114837.htm UT Southwestern Medical Center. "Generic cholesterol drugs save Medicare billions of dollars: Between 2014 and 2018, the number of Medicare beneficiaries on cholesterol drugs went up, but total costs plummeted." ScienceDaily. www.sciencedaily.com/releases/2020/09/200909114837.htm (accessed September 10, 2020).
advertisement 1

2

3

4

5

RELATED STORIES

Medicare Patients With Multiple Sclerosis Bear the Burden of Rising Drug Prices

Aug. 26, 2019 — In a decade, Medicare recipients saw a sevenfold increase in out of pocket costs for multiple sclerosis drugs. Spending on these drugs by Medicare itself increased by …

Statins Save Lives of People With High Levels of LDL Cholesterol

Apr. 17, 2018 — Cholesterol-lowering drugs are more likely to save thousands of additional lives when used in people with higher levels of LDL cholesterol, or 'bad' cholesterol, according to a new …

Rising Costs, Potential Savings for Generic, Topical Steroids

Apr. 28, 2017 — Although most topical steroids prescribed to patients were generic in a new American study, there was a sharp increase in Medicare Part D and out-of-pocket spending for elderly patients taking these …

Patients' Annual Financial Burden Under Medicare Part D Is 'Too Much Too Soon'

Mar. 17, 2017 — A study documents the patient out-of-pocket cost burden under Medicare prescription drug plans (known as Medicare Part D) and finds that despite having insurance, Medicare patients using specialty … FROM AROUND THE WEB Below are relevant articles that may interest you. ScienceDaily shares links with scholarly publications in the TrendMD network and earns revenue from third-party advertisers, where indicated. Print Email Share advertisement 1

2

3

4

5

Most Popular this week HEALTH & MEDICINE

Stroke Warning Signs Often Occur Hours Or Days Before Attack
Generic Cholesterol Drugs Save Medicare Billions Of Dollars: Between 2014 And 2018, The Number Of Medicare Beneficiaries On Cholesterol Drugs Went Up, But Total Costs Plummeted - Science DailyResearchers Discover a Specific Brain Circuit Damaged by Social Isolation During Childhood
Venom from Honeybees Found to Kill Aggressive Breast Cancer Cells

MIND & BRAIN

Common Class of Drugs Linked to Increased Risk of Alzheimer's Disease
Loss of Smell and Taste Validated as COVID-19 Symptoms in Patients With High Recovery Rate
(c) (c) ipopba / Adobe - Generic Cholesterol Drugs Save Medicare Billions Of Dollars: Between 2014 And 2018, The Number Of Medicare Beneficiaries On Cholesterol Drugs Went Up, But Total Costs Plummeted - Science DailyUnconscious Learning Underlies Belief in God, Study Suggests

LIVING & WELL

Boy or Girl? It's in the Father's Genes
(c) (c) ipopba / Adobe - Generic Cholesterol Drugs Save Medicare Billions Of Dollars: Between 2014 And 2018, The Number Of Medicare Beneficiaries On Cholesterol Drugs Went Up, But Total Costs Plummeted - Science DailyUnconscious Learning Underlies Belief in God, Study Suggests
Red Hot Meat: The Wrong Recipe for Heart Disease

advertisement